Basic earnings or loss per share is based on the weighted average number of common shares issued and outstanding. In computing diluted earnings per share, basic earnings per share is adjusted for the assumed issuance of all potentially dilutive securities, including the Company’s (i) employee stock options and (ii) non-vested restricted stock units and performance stock units (collectively, the “Stock Units”).

In periods in which the Company has a net loss, diluted loss per share is based on the weighted average number of common shares issued and outstanding as the effect of including common stock equivalents outstanding would be anti-dilutive. As the Company was in a net loss position for the fifty-two weeks ended August 29, 2026, 0.2 million shares of common stock issuable upon exercise of stock options and non-vested Stock Units were excluded from the diluted earnings per share computation.


	52-Weeks Ended		52-Weeks Ended		53-Weeks Ended
(In thousands, except share and per share data)	August 29, 2026		August 30, 2025		August 31, 2024
Basic (loss) earnings per share computation:
Numerator:
Net (loss) income available to common stock stockholders	$	(155,903)	$	103,614	$	139,309
Denominator:
Weighted average common shares outstanding – basic	92,372,473		100,695,181		99,929,196
Basic (loss) earnings per share from net (loss) income	$	(1.69)	$	1.03	$	1.39

Diluted (loss) earnings per share computation:
Numerator:
Net (loss) income available to common stock stockholders	$	(155,903)	$	103,614	$	139,309

Denominator:
Weighted average common shares outstanding – basic	92,372,473		100,695,181		99,929,196
Employee stock options	—		629,800		1,112,459
Non-vested stock units	—		185,791		240,233
Weighted average common shares – diluted	92,372,473		101,510,772		101,281,888
Diluted (loss) earnings per share from net (loss) income	$	(1.69)	$	1.02	$	1.38

Diluted earnings per share calculations for the fifty-two weeks ended August 29, 2026, the fifty-two weeks ended August 30, 2025, and the fifty-three weeks ended August 31, 2024, excluded 3.0 million shares, 0.7 million shares, and 0.8 million shares of common stock issuable upon exercise of stock options and non-vested Stock Units, respectively, that would have been anti-dilutive.